• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向非常规结合位点诱导乙肝核心蛋白聚集

Induction of hepatitis B core protein aggregation targeting an unconventional binding site.

作者信息

Khayenko Vladimir, Makbul Cihan, Schulte Clemens, Hemmelmann Naomi, Kachler Sonja, Böttcher Bettina, Maric Hans Michael

机构信息

Rudolf Virchow Center, Center for Integrative and Translational Bioimaging; University of Würzburg, Würzburg, Germany.

Biocenter, University of Würzburg, Würzburg, Germany.

出版信息

Elife. 2025 Mar 26;13:RP98827. doi: 10.7554/eLife.98827.

DOI:10.7554/eLife.98827
PMID:40135596
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11942178/
Abstract

The hepatitis B virus (HBV) infection is a major global health problem, with chronic infection leading to liver complications and high death toll. Current treatments, such as nucleos(t)ide analogs and interferon-α, effectively suppress viral replication but rarely cure the infection. To address this, new antivirals targeting different components of the HBV molecular machinery are being developed. Here we investigated the hepatitis B core protein (HBc) that forms the viral capsids and plays a vital role in the HBV life cycle. We explored two distinct binding pockets on the HBV capsid: the central hydrophobic pocket of HBc-dimers and the pocket at the tips of capsid spikes. We synthesized a geranyl dimer that binds to the central pocket with micromolar affinity, and dimeric peptides that bind the spike-tip pocket with sub-micromolar affinity. Cryo-electron microscopy further confirmed the binding of peptide dimers to the capsid spike tips and their capsid-aggregating properties. Finally, we show that the peptide dimers induce HBc aggregation in vitro and in living cells. Our findings highlight two tractable sites within the HBV capsid and provide an alternative strategy to affect HBV capsids.

摘要

乙型肝炎病毒(HBV)感染是一个重大的全球健康问题,慢性感染会导致肝脏并发症并造成高死亡率。目前的治疗方法,如核苷(酸)类似物和α干扰素,能有效抑制病毒复制,但很少能治愈感染。为了解决这一问题,正在研发针对HBV分子机制不同组成部分的新型抗病毒药物。在此,我们研究了形成病毒衣壳并在HBV生命周期中起关键作用的乙型肝炎核心蛋白(HBc)。我们探索了HBV衣壳上两个不同的结合口袋:HBc二聚体的中央疏水口袋和衣壳尖峰处的口袋。我们合成了一种以微摩尔亲和力与中央口袋结合的香叶基二聚体,以及以亚微摩尔亲和力与尖峰末端口袋结合的二聚体肽。冷冻电子显微镜进一步证实了肽二聚体与衣壳尖峰末端的结合及其衣壳聚集特性。最后,我们表明肽二聚体在体外和活细胞中诱导HBc聚集。我们的研究结果突出了HBV衣壳内两个易于处理的位点,并提供了一种影响HBV衣壳的替代策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/eb539fb15f1b/elife-98827-app1-fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/cbecaad989e3/elife-98827-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/d88a9d55b643/elife-98827-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/35e23ff374df/elife-98827-fig2-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/5775279630da/elife-98827-fig2-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/b0813eb41cd3/elife-98827-fig2-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/32e70d144e4f/elife-98827-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/4f30e373a9e8/elife-98827-fig3-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/a90676ede2c7/elife-98827-fig3-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/757c9f90804b/elife-98827-fig3-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/8347ac3ff714/elife-98827-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/d1f54fafab40/elife-98827-fig4-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/c064aaa5b405/elife-98827-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/769b45ef42c9/elife-98827-fig5-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/1b327a2c9ff7/elife-98827-fig5-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/b861f2a54ab7/elife-98827-fig5-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/e239a8cbbb72/elife-98827-app1-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/5eedbf6c97cd/elife-98827-app1-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/2389510a5bbb/elife-98827-app1-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/89f74537d0f1/elife-98827-app1-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/432f4ce75839/elife-98827-app1-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/1f0016c762e3/elife-98827-app1-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/55dd56de59d3/elife-98827-app1-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/a32ff3eea5b9/elife-98827-app1-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/eb539fb15f1b/elife-98827-app1-fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/cbecaad989e3/elife-98827-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/d88a9d55b643/elife-98827-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/35e23ff374df/elife-98827-fig2-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/5775279630da/elife-98827-fig2-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/b0813eb41cd3/elife-98827-fig2-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/32e70d144e4f/elife-98827-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/4f30e373a9e8/elife-98827-fig3-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/a90676ede2c7/elife-98827-fig3-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/757c9f90804b/elife-98827-fig3-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/8347ac3ff714/elife-98827-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/d1f54fafab40/elife-98827-fig4-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/c064aaa5b405/elife-98827-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/769b45ef42c9/elife-98827-fig5-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/1b327a2c9ff7/elife-98827-fig5-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/b861f2a54ab7/elife-98827-fig5-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/e239a8cbbb72/elife-98827-app1-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/5eedbf6c97cd/elife-98827-app1-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/2389510a5bbb/elife-98827-app1-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/89f74537d0f1/elife-98827-app1-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/432f4ce75839/elife-98827-app1-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/1f0016c762e3/elife-98827-app1-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/55dd56de59d3/elife-98827-app1-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/a32ff3eea5b9/elife-98827-app1-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2f0/11942178/eb539fb15f1b/elife-98827-app1-fig9.jpg

相似文献

1
Induction of hepatitis B core protein aggregation targeting an unconventional binding site.靶向非常规结合位点诱导乙肝核心蛋白聚集
Elife. 2025 Mar 26;13:RP98827. doi: 10.7554/eLife.98827.
2
Assembly Properties of Hepatitis B Virus Core Protein Mutants Correlate with Their Resistance to Assembly-Directed Antivirals.乙肝病毒核心蛋白突变体的组装特性与其对组装定向抗病毒药物的耐药性相关。
J Virol. 2018 Sep 26;92(20). doi: 10.1128/JVI.01082-18. Print 2018 Oct 15.
3
Cell-Free Hepatitis B Virus Capsid Assembly Dependent on the Core Protein C-Terminal Domain and Regulated by Phosphorylation.依赖核心蛋白C末端结构域并受磷酸化调控的无细胞乙肝病毒衣壳组装
J Virol. 2016 May 27;90(12):5830-5844. doi: 10.1128/JVI.00394-16. Print 2016 Jun 15.
4
Selective depletion of HBV-infected hepatocytes by class A capsid assembly modulators requires high levels of intrahepatic HBV core protein.A 类衣壳组装调节剂选择性耗竭 HBV 感染的肝细胞需要高水平的肝内 HBV 核心蛋白。
Antimicrob Agents Chemother. 2024 Jul 9;68(7):e0042024. doi: 10.1128/aac.00420-24. Epub 2024 May 23.
5
Core Protein-Directed Antivirals and Importin β Can Synergistically Disrupt Hepatitis B Virus Capsids.核心蛋白定向抗病毒药物和 Importin β 可协同破坏乙型肝炎病毒衣壳。
J Virol. 2022 Jan 26;96(2):e0139521. doi: 10.1128/JVI.01395-21. Epub 2021 Oct 27.
6
Hepatitis B Virus Capsids Have Diverse Structural Responses to Small-Molecule Ligands Bound to the Heteroaryldihydropyrimidine Pocket.乙肝病毒衣壳对结合于杂芳基二氢嘧啶口袋的小分子配体具有多样的结构响应。
J Virol. 2016 Mar 28;90(8):3994-4004. doi: 10.1128/JVI.03058-15. Print 2016 Apr.
7
Discovery and Mechanistic Study of Benzamide Derivatives That Modulate Hepatitis B Virus Capsid Assembly.调节乙型肝炎病毒衣壳组装的苯甲酰胺衍生物的发现与机制研究
J Virol. 2017 Jul 27;91(16). doi: 10.1128/JVI.00519-17. Print 2017 Aug 15.
8
Hepatitis B Virus Core Protein Is Not Required for Covalently Closed Circular DNA Transcriptional Regulation.乙型肝炎病毒核心蛋白对于共价闭合环状 DNA 的转录调控并非必需。
J Virol. 2022 Nov 9;96(21):e0136222. doi: 10.1128/jvi.01362-22. Epub 2022 Oct 13.
9
BAY 41-4109-mediated aggregation of assembled and misassembled HBV capsids in cells revealed by electron microscopy.电子显微镜揭示了 BAY 41-4109 介导的组装和错误组装的 HBV 衣壳在细胞中的聚集。
Antiviral Res. 2019 Sep;169:104557. doi: 10.1016/j.antiviral.2019.104557. Epub 2019 Jul 11.
10
The diverse functions of the hepatitis B core/capsid protein (HBc) in the viral life cycle: Implications for the development of HBc-targeting antivirals.乙型肝炎核心/衣壳蛋白(HBc)在病毒生命周期中的多种功能:对开发针对 HBc 的抗病毒药物的影响。
Antiviral Res. 2018 Jan;149:211-220. doi: 10.1016/j.antiviral.2017.11.015. Epub 2017 Nov 26.

本文引用的文献

1
SARS-CoV-2 Vaccine-Induced Humoral Immunity in Immunocompetent European Adults: A Systematic Review.免疫功能正常的欧洲成年人中SARS-CoV-2疫苗诱导的体液免疫:一项系统评价
Microorganisms. 2025 Feb 27;13(3):535. doi: 10.3390/microorganisms13030535.
2
Novel Minimally Invasive Surgical Approaches to Endometriosis and Adenomyosis: A Comprehensive Review.子宫内膜异位症和子宫腺肌病的新型微创外科手术方法:综述
J Clin Med. 2024 Nov 14;13(22):6844. doi: 10.3390/jcm13226844.
3
A robust normalized local filter to estimate compositional heterogeneity directly from cryo-EM maps.
一种稳健的归一化局部滤波器,可直接从冷冻电镜图中估计组成异质性。
Nat Commun. 2023 Sep 19;14(1):5802. doi: 10.1038/s41467-023-41478-1.
4
Evaluation of RNAi therapeutics VIR-2218 and ALN-HBV for chronic hepatitis B: Results from randomized clinical trials.评估 RNAi 疗法 VIR-2218 和 ALN-HBV 治疗慢性乙型肝炎的效果:随机临床试验结果。
J Hepatol. 2023 Oct;79(4):924-932. doi: 10.1016/j.jhep.2023.05.023. Epub 2023 Jun 7.
5
Canocapavir Is a Novel Capsid Assembly Modulator Inducing a Conformational Change of the Linker Region of HBV Core Protein.坎卡匹韦是一种新型衣壳组装调节剂,诱导 HBV 核心蛋白连接区构象发生变化。
Viruses. 2023 May 18;15(5):1195. doi: 10.3390/v15051195.
6
Hepatitis B.乙型肝炎
Lancet. 2023 Mar 25;401(10381):1039-1052. doi: 10.1016/S0140-6736(22)01468-4. Epub 2023 Feb 9.
7
Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection.比匹韦林治疗慢性乙型肝炎感染的疗效和安全性
N Engl J Med. 2022 Nov 24;387(21):1957-1968. doi: 10.1056/NEJMoa2210027. Epub 2022 Nov 8.
8
Nano-optical designs for high-efficiency monolithic perovskite-silicon tandem solar cells.用于高效单片钙钛矿-硅串联太阳能电池的纳米光学设计。
Nat Nanotechnol. 2022 Nov;17(11):1214-1221. doi: 10.1038/s41565-022-01228-8. Epub 2022 Oct 24.
9
Nomenclature of HBV core protein-targeting antivirals.靶向乙肝病毒核心蛋白的抗病毒药物的命名
Nat Rev Gastroenterol Hepatol. 2022 Dec;19(12):748-750. doi: 10.1038/s41575-022-00700-z.
10
Pharmacomodulation of a ligand targeting the HBV capsid hydrophobic pocket.靶向乙肝病毒衣壳疏水口袋的配体的药物调节作用
Chem Sci. 2022 Jul 7;13(30):8840-8847. doi: 10.1039/d2sc02420a. eCollection 2022 Aug 4.